Atlas Trials

Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II

Clinical trial NCT06706791 · RECRUITING

Trial details

NCT number
NCT06706791
Sponsor
Fazaia Ruth Pfau Medical College
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Heart Failure
Start date
2025-04-01
Primary completion
2026-06-01
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.